Telix Pharmaceuticals Limited (TLPPF) Free cash flow 2023–2025
Telix Pharmaceuticals Limited (TLPPF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$43.0MFY2025 · since FY2023: $8.0M → -$43.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$43.0M | -334.0% |
| FY2024 | $18.4M | +130.6% |
| FY2023 | $8.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLPPF financial trends
TLPPF RevenueTLPPF Net incomeTLPPF Net marginTLPPF Gross profitTLPPF Gross marginTLPPF Operating incomeTLPPF Operating marginTLPPF Operating cash flowTLPPF Capital expendituresTLPPF Return on equityTLPPF Stock buybacksTLPPF Dividends paidTLPPF Total assetsTLPPF Total liabilitiesTLPPF Shareholders’ equityTLPPF overview →